Le Lézard
Classified in: Health, Science and technology, Business
Subjects: NPT, LIC

Melax Tech, Renowned NLP Tech Firm, Announces Sponsorship of BioSpark Group


HOUSTON, Dec. 2, 2021 /PRNewswire/ -- Houston-based Natural Language Processing (NLP) technology firm Melax Tech announced today that it has joined in a sponsorship arrangement with Cambridge, Massachusetts-based BioSpark Group. BioSpark, a non-profit organization, is focused on establishing a scholar and entrepreneurship network and facilitating scientific translations within the biomedical field. Melax Tech is known internationally for its award-winning work in text annotation and extraction within the life sciences and biomedical domains. 

By aligning with BioSpark Group, Melax Tech expects to continue growth in unstructured text data extraction and normalization in biopharma R&D applications, as members in BioSpark's community could access Melax Tech's CLAMP framework to explore uses for the technology.

"The relationship between Melax Tech and BioSpark Group comes naturally, as both the group's members and our company are invested in improving the quality of healthcare and care reporting, and breakthroughs in pharma and medicine," said Andre Pontin, CEO of Melax Tech. "We look forward to showcasing our software capabilities in educational programs to BioSpark members during the coming year."

The Melax Tech sponsorship will begin in January, 2022. Among the projects Melax Tech will offer BioSpark members is a webinar to introduce the range of possibilities Melax Tech's CLAMP software offers to researchers.

About Melax Tech:
Melax Tech has an array of software built on CLAMP, as on-premises or cloud-based options. Mercury is a self-service, pay-as-you-go text annotation product for medical and life science projects. LANN, a literature annotation tool, allows researchers in pharma and related industries to locate references to diseases, medications, ADEs and usage patterns. VITAL is chart review software that, among other uses, improves areas such as billing and coding accuracy.  All Melax Tech's products offer options to develop projects that involve social media and telemedicine.

To learn more about Melax Tech NLP technology, visit www.melaxtech.com. To learn about BioSpark Group and its activities, visit www.biospark.org.

SOURCE Melax Technologies, Inc.


These press releases may also interest you

at 18:45
IANS Research Receives Strategic Investment From the Apax Digital Funds to Accelerate Growth and Market Leadership in Information Security
IANS Research, the leading provider of independent research and advisory services for the information security industry, has announced a new strategic investment from the Apax Digital Fund II (the "Apax Digital Funds"). IANS is a widely recognized...

at 18:45
Monster Energy Snowboard Athletes Release Visually Stunning "Green Hour" Video
Monster Energy Releases Nine-Minute Video Showcasing Professional Snowboarders Ståle Sandbech, Torgeir Bergrem, and Rene Rinnekangas Riding Beneath the Northern Lights in the Backcountry of Norway "We had this vision or this idea to...

at 18:37
University of Maryland's Smith School of Business Launches Center for Artificial Intelligence in Business
The University of Maryland's Robert H. Smith School of Business has launched the Center for Artificial Intelligence in Business to conduct research and outreach in order to realize the potential of AI through intentional design and governance...

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:50
Cantaloupe, Inc. to Report Third Quarter Fiscal Year 2024 Results on May 9, 2024
Cantaloupe, Inc. , a leading provider of end-to-end technology solutions for self-service commerce, today announced that management will host a webcast to discuss its financial results for the third quarter of fiscal year 2024 on Thursday, May 9,...

at 17:31
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

More news about Science and technology...


News published on and distributed by: